Blog
RSS FeedPosted by Michael Wonder on 18 Jul 2017
Spark Therapeutics’ biologics license application for investigational voretigene neparvovec accepted for filing by FDA
17 July 2017 - FDA grants priority review with PDUFA date of 12 January 2018. ...
Posted by Michael Wonder on 18 Jul 2017
Trump health bill all but dead
18 July 2017 - Republicans Mike Lee of Utah and Jerry Moran of Kansas said they would oppose the Republican ...
Posted by Michael Wonder on 17 Jul 2017
Institute for Clinical and Economic Review's final evidence report finds prices of anabolic agents for osteoporosis too high, not aligned with potential benefits over other treatments
17 July 2017 - Policy recommendations highlight need for prices to align with clinical benefit, clear guidelines to define highest ...
Posted by Michael Wonder on 17 Jul 2017
How the Republican health care bill could raise premiums for 177 million Americans
17 July 2017 - A leading business coalition has warned that employers could pick up the tab if millions of ...
Posted by Michael Wonder on 17 Jul 2017
A top Republican vows a vote on health care, but uncertainty reigns
16 July 2017 - A top Senate Republican vowed on Sunday to bring the party’s health care bill to a ...
Posted by Michael Wonder on 17 Jul 2017
New “let’s talk about cost” campaign convenes national dialogue on medicine costs
12 July 2017 - Discussions about costs are important. ...
Posted by Michael Wonder on 17 Jul 2017
The art of the deal? Why a money-back guarantee for drugs is a bad idea
17 July 2017 - President Trump likes to boast that he mastered the “art of the deal.” ...
Posted by Michael Wonder on 17 Jul 2017
Building a strong FDA workforce to bring scientific advances to patients
17 July 2017 - The key to FDA’s public health mission, and its ability to bring innovative new therapies to patients, ...
Posted by Michael Wonder on 17 Jul 2017
FDA approves new treatment to reduce the risk of breast cancer returning
17 July 2017 - The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, ...
Posted by Michael Wonder on 17 Jul 2017
Trump health care bill vote delayed for John McCain health reasons
17 July 2017 - It's a hell of a gamble when you rely on a sick man. ...
Posted by Michael Wonder on 17 Jul 2017
Amgen and UCB provide update on regulatory status of Evenity (romosozumab) in the US
16 July 2017 - Amgen and UCB today announced that the U.S. FDA has issued a complete response letter for ...
Posted by Michael Wonder on 17 Jul 2017
Amgen submits regulatory applications in US and Europe to include overall survival data in Kyprolis (carfilzomib) label
14 July 2017 - Data showed Kyprolis and dexamethasone reduced the risk of death by 21% and increased overall survival ...
Posted by Michael Wonder on 15 Jul 2017
Governors from both parties denounce Senate Obamacare Repeal Bill
14 July 2017 - The nation’s governors, gathered here for their annual summer meeting, came out strongly on Friday against ...
Posted by Michael Wonder on 15 Jul 2017
U.S. health care system has widest gap between people with higher and lower incomes
14 July 2017 - New international ranking underscores the importance of health insurance coverage and strong primary care. ...
Posted by Michael Wonder on 15 Jul 2017
Trumpcare, version three
14 July 2017 - Is the Senate’s revised health-care proposal a good bill? And will it pass? ...